Bolt Biotherapeutics Financial Overview
Bolt Biotherapeutics's market cap is currently $9.90M. The company's EPS TTM is $-3.72; its P/E ratio is -0.23; Bolt Biotherapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-5.63. See an overview of income statement, balance sheet, and cash flow financials.
